WIL Research adds two executives


Appoints chief information officer and chief commercial officer

WIL Research Company, a global contract research organisation (CRO) and provider of drug development and chemical and food safety services, has appointed Howard Moody as chief information officer and Alan Findlater as chief commercial officer.

Moody will oversee the development and execution of an information technology strategy that improves client service, increases efficiency and expands enterprise value. Findlater will be responsible for a global business development and marketing strategy that strengthens client relationships and expands market share.

Moody brings more than 20 years of experience in the contract research and laboratory services industries to WIL. Most recently, he was cio at MDS Pharma Services. Prior to this, he was cio at Medifacts, a cardiac safety service provider, and spent five years as cio at Covance.

Findlater has more than eight years of business development experience in the pre-clinical contract research sector and more than 13 years of pharmaceutical marketing experience. Most recently, he was global vice president of sales and client services for the non-clinical safety assessment and analytical services divisions at Covance. Previously, he was Covance’s vice president of business development in Europe before moving to the US and being appointed vp of sales and client services for North America. Prior to joining Covance, he worked for more than eight years at Johnson & Johnson in a number of marketing and account management roles.